Phase II, Open Label, Adaptive Design, Multiple Dose Finding Study to Investigate Synthetic PreImplantationFactor (sPIF) in Patients With Autoimmune Hepatitis (AIH) Phase II, Open Label, Adaptive Design, Multiple Dose Finding Study to Investigate Synthetic PreImpla ...
sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Synthetic PreImplantationFactor (sPIF) in Autoimmune Hepatitis A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to ...